New guidance is asking “civil servants to break the law”, says FDA

FDA General Secretary Dave Penman has strongly criticised new guidance issued to civil servants, as it puts them in an “invidious position” and calls into question the integrity of the civil service, which has an obligation to uphold the rule of law, whether that is domestic or international law.
The guidance states that decisions whether to comply with a Rule 39 injunction from the European Court of Human Rights (ECHR) and the “implications of such a decision in respect of the UK’s international obligations are a matter for ministers”, not civil servants.
Penman argued there is a clear difference between not asking civil servants to breach international law, and telling them not to worry about breaching international law. He told the Guardian that “changing guidance… does not change the facts… If the ECHR rules a deportation unlawful, those are the facts of the case”.
“Ministers are trying to put civil servants in an invidious position by placing them between serving ministers and their professional obligations, he added. “It looks as if ministers are trying to avoid leaving the ECHR and are asking civil servants to break the law instead.”
Speaking to John Pienaar on Times Radio, the General Secretary said that he interprets the new guidance as ministers putting civil servants in the middle of “an internal dispute within the Conservative Party”.
Related News
-
Under significant pressure: Interview with Director of Public Prosecutions
Tom Nathan speaks to Crown Prosecution Service Director of Public Prosecutions Stephen Parkinson about CPS’s handling of riots, the importance of impartiality and his plan to help reduce unmanageable prosecutor caseloads.
-
Changing the culture
HM Chief Inspector Sir Martyn Oliver sat down for an ‘in conversation’ event with FDA General Secretary Dave Penman, discussing the pace of change in Ofsted, challenging perceptions and tackling the long hours culture in Education.
-
Hybrid working: Led by evidence, not headlines
Tom Nathan shares the findings and recommendations of the FDA’s recent report on ‘The future of office working in the civil service’.